22 Results

People

  1. Fornier
    Fornier
  2. Morris
    Morris
  3. Sonoda
    Sonoda
  4. Abrey
    Abrey
  5. Bajorin
    Bajorin
  6. Cassileth
    Cassileth
  7. Chi
    Chi
  8. Chou
    Chou
  9. Dang
    Dang
  10. Gerecitano
    Gerecitano

Groups

  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (9)
  3. Breast Medicine Service (4)
  4. Hematologic Malignancies, Division of (4)
  5. Surgery (4)
  6. Survivorship Research (4)
  7. Gynecology Disease Management Team (3)
  8. GDMT, Surgery (2)
  9. Genitourinary Oncology Service (2)
  10. Center for Hematologic Malignancies (1)
  1. "clinical trial"
  2. "Expert Review of Anticancer Therapy"
Formats
  1. Journal Article (21)
  2. Review (1)
Groups
  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (9)
  3. Breast Medicine Service (4)
  4. Hematologic Malignancies, Division of (4)
  5. Surgery (4)
  6. Survivorship Research (4)

More Groups

People
  1. Monica Fornier (2)
  2. Patrick Morris (2)
  3. Yukio Sonoda (2)
  4. Alexander Chou (1)
  5. Barrie Cassileth (1)
  6. Chau Dang (1)

More People

Years
  1. 2023 (1)
  2. 2010 (3)
  3. 2009 (5)
  4. 2008 (4)
  5. 2006 (3)
  6. 2005 (1)

More Years

Publications
  1. Expert Review of Anticancer Therapy (22)
Publishers
  1. Taylor & Francis Group (22)

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
    Review

    Yang, J. C. H.; Zhou, C.; Jänne, P. A.; Ramalingam, S. S.; Kim, T. M.; Riely, G. J.; Spira, A. I.; Piotrowska, Z.; Mekhail, T.; Garcia Campelo, M. R.; more...
    Expert Review of Anticancer Therapy (2023)

    Fulltext@MSK | Save
  • Ipilimumab: Attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma
    Journal Article

    Peggs, K. S.; Quezada, S. A.
    Expert Review of Anticancer Therapy (2010)

    Fulltext@MSK | Save
  • Optimal management of uterine leiomyosarcoma
    Journal Article

    O'cearbhaill, R.; Hensley, M. L.
    Expert Review of Anticancer Therapy (2010)

    Fulltext@MSK | Save
  • Novel strategies for treating relapsed/refractory urothelial carcinoma
    Journal Article

    Iyer, G.; Milowsky, M. I.; Bajorin, D. F.
    Expert Review of Anticancer Therapy (2010)

    Fulltext@MSK | Save
  • Is there a role for complementary therapy in the management of leukemia?
    Journal Article

    Wesa, K. M.; Cassileth, B. R.
    Expert Review of Anticancer Therapy (2009)

    Fulltext@MSK | Save
  • Personalizing therapy for metastatic breast cancer
    Journal Article

    Morris, P. G.; Hudis, C. A.
    Expert Review of Anticancer Therapy (2009)

    Fulltext@MSK | Save
  • Novel anti-tubulin cytotoxic agents for breast cancer
    Journal Article

    Morris, P. G.; Fornier, M. N.
    Expert Review of Anticancer Therapy (2009)

    Fulltext@MSK | Save
  • Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma
    Journal Article

    Meyers, P. A.
    Expert Review of Anticancer Therapy (2009)

    Fulltext@MSK | Save
  • Concurrent chemotherapy and radiotherapy for head and neck cancer
    Journal Article

    Burri, R. J.; Lee, N. Y.
    Expert Review of Anticancer Therapy (2009)

    Fulltext@MSK | Save
  • Tribulations or triumphs in prostate cancer immunotherapy: On the road to victory?
    Journal Article

    Slovin, S. F.
    Expert Review of Anticancer Therapy (2008)

    Fulltext@MSK | Save